| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 6, 2006
From Cardiac & Vascular Sciences (Dermatology) (R.H.M, A.W.B.S, P.S.M.), Clinical Genetics (G.B.), Clinical Developmental Sciences (S.J.), and Physiology (J.R.L.), St George’s, University of London, London, UK; Vascular Laboratory (J.F.), St George’s Hospital, London, UK; and Department of Academic Surgery (A.S, K.G.B.), St Thomas’ Hospital, London, UK. Dr Mellor, G. Brice, Dr Smith, Prof Jeffery, Prof Burnand, and Prof Mortimer represent the Lymphoedema Research Consortium. * To whom correspondence should be addressed. E-mail: mortimer{at}sgul.ac.uk.
Background--Mutations in the FOXC2 gene cause lymphedema distichiasis, an inherited primary lymphedema in which a significant number of patients have varicose veins. Because lymphedema distichiasis is believed to be caused by lymphatic valve failure (reflux), and FOXC2 is highly expressed on venous valves in mouse embryos, we tested the hypothesis that FOXC2 mutations may be linked to venous valve failure and reflux. Methods and Results--The venous system of the leg was investigated with Duplex ultrasound. Pathological reflux was recorded by color Duplex ultrasound in all 18 participants with a FOXC2 mutation, including 3 without lymphedema. Every participant with a mutation in FOXC2 showed reflux in the great saphenous vein (n=18), compared with only 1 of 12 referents (including 10 family members; P<0.0001, Fisher exact test). Deep vein reflux was recorded in 14 of 18 participants. Conclusions--FOXC2 is the first gene in which mutations have been strongly associated with primary venous valve failure in both the superficial and deep veins in the lower limb. This gene appears to be important for the normal development and maintenance of venous and lymphatic valves.
Accepted on January 5, 2007
Mutations in FOXC2 Are Strongly Associated With Primary Valve Failure in Veins of the Lower Limb
Russell H. Mellor PhD,
This article has been cited by other articles:
![]() |
C. Norrmen, K. I. Ivanov, J. Cheng, N. Zangger, M. Delorenzi, M. Jaquet, N. Miura, P. Puolakkainen, V. Horsley, J. Hu, et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1 J. Cell Biol., May 4, 2009; 185(3): 439 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zarogiannis, C. Hatzoglou, P.-A. Molyvdas, and K. Gourgoulianis Yellow Nail Syndrome Chylous Pleural Effusions: Defective Lymph Valves Involved? Chest, December 1, 2008; 134(6): 1353 - 1353. [Full Text] [PDF] |
||||
![]() |
R J Damstra and P S Mortimer Diagnosis and therapy in children with lymphoedema Phlebology, December 1, 2008; 23(6): 276 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayashi, H. Sano, S. Seo, and T. Kume The Foxc2 Transcription Factor Regulates Angiogenesis via Induction of Integrin {beta}3 Expression J. Biol. Chem., August 29, 2008; 283(35): 23791 - 23800. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Papanicolaou, Y. Izumiya, and K. Walsh Forkhead Transcription Factors and Cardiovascular Biology Circ. Res., January 4, 2008; 102(1): 16 - 31. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |